Pacira BioSciences Inc (PCRX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$23.01

Buy

$26.32

arrow-up$0.56 (+2.18%)

Prices updated at 12 Dec 2025, 22:56 EST

Prices minimum 15 mins delay

Prices in USD

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	675m	701m
	490m	531m
	87m	98m
	12.94	13.92
	42m	-100m
	155m	29m
Sales, General and administrative	269m	294m
Interest expenses	17m	13m
Provision for income taxes	20m	36m
Operating expenses	403m	433m
Income before taxes	62m	-63m
Net income available to common shareholders	42m	-100m
	0.91	-2.15
Net interest income	-9m	3m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.89	-2.15
Free cash flow per share	2.8263	3.7271
Book value/share	17.8901	16.2105
Debt equity ratio	0.653468	0.550127

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	510m	745m
Current liabilities	97m	310m
Total capital	1,384m	1,162m
Total debt	586m	639m
Total equity	870m	778m
Total non current liabilities	-	-
Loans	514m	384m
Total assets	1,574m	1,554m
Total liabilities	-	-
Cash and cash equivalents	153m	277m
Common stock	46m	46m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	104m	153m
Cash dividends paid	-	-
	139m	179m
Investments (gains) losses	78m	-83m
	153m	277m
Net income	-	-
	155m	189m
	-15m	-11m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.